Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Primary Axillary Hyperhydrosis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S40, 2018. DOI: 10.25251/skin.2.supp.40. Disponível em: https://skin.dermsquared.com/skin/article/view/268. Acesso em: 13 apr. 2025.